PA
TPR icon

PharVision Advisers’s Tapestry TPR Stock Holding History

PharVision Advisers’s Portfolio TPR Stock Details TPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,674
Closed -$259K – 430
2025
Q1 		$259K Sell
3,674
-1,129
-24% -$85.4K 0.36% 130
2024
Q4 		$314K Buy
+4,803
New +$262K 0.27% 137

Other funds holding TPR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIM
SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

PharVision Advisers's TPR Position: Q2 2025 in Review

PharVision Advisers sold out of Tapestry (TPR) in Q2 2025, closing a stake of 3,674 shares — an estimated $259K sold.

PharVision Advisers first reported a position in TPR in Q4 2024 and held it in 2 quarters. The position peaked at $314K in Q4 2024. 874 funds tracked by Wall St. Rank hold TPR as of Q2 2025.

  • PharVision Advisers reported no remaining Tapestry position as of Q2 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,674 Tapestry shares in Q2 2025, an estimated $259K.
  • PharVision Advisers first reported a position in Tapestry in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Tapestry position peaked at $314K in Q4 2024.
  • 874 funds tracked by Wall St. Rank held Tapestry as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.